[24] Amyloid-ß has also been shown to activate the NLRP3 inflammasome in a mouse model of Alzheimer’s disease. [25] Targeting amyloid appears to protect against RPE damage and vision loss in a model of age-related macular degeneration. [26]. Here, NLRP3 is linked to early-onset autosomal dominant Alzheimer disease.